National Health (Pharmaceuticals and Vaccines—Cost Recovery) Regulations 2022
63Delay in paying fee
Start here
Get a plain-English read of 63
Turn the raw legal text into a practical explanation grounded in National Health (Pharmaceuticals and Vaccines—Cost Recovery) Regulations 2022.
63 Delay in paying fee
(1) If a fee payable under this instrument by a person is not paid before the time the fee must be paid, the Commonwealth may do either or both of the following until the fee is paid or is no longer payable: (a) refuse to consider a submission or application made (or to be made) by the person under this instrument; (b) refuse to provide any services relating to a submission or an application made under this instrument.
Note 1: Paragraph (a) means, for example, that the Committee or ATAGI could refuse to consider the person’s current or future submissions or applications made under this instrument until the fee is paid or is no longer payable.
Note 2: The Commonwealth could, instead of or in addition to refusing to do these things, seek to recover the unpaid fee as a debt (see subsection 99YBA(5) of the Act).
(2) This section does not apply in relation to a fee prescribed by section 64 (independent review fee).